Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures
Clinical trial NCT00530855 · COMPLETED
Trial details
- NCT number
- NCT00530855
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-02-01
- Primary completion
- 2014-12-01
- Enrollment
- 322
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.